SPDB International Holdings logo

SPDB International Holdings

Asia, Hong Kong Island, Hong Kong, Hong Kong

Description

SPDB International Holdings is an offshore investment bank.

Investor Profile

SPDB International Holdings has made 3 investments, with 0 in the past 12 months and 67% as lead.

Stage Focus

  • Series A (33%)
  • Series E (33%)
  • Series D (33%)

Country Focus

  • China (67%)
  • United States (33%)

Industry Focus

  • Architecture
  • Internet
  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Analytics
  • Enterprise Software
  • Information Technology
  • Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does SPDB International Holdings frequently co-invest with?

Lighthouse Capital Management
Asia, Shanghai, China, Shanghai
Co-Investments: 1
IDG Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Hillhouse Investment
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Morningside Group
North America, Massachusetts, United States, Newton Center
Co-Investments: 1
Chuxin Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
BAI capital
Asia, Beijing, China, Beijing
Co-Investments: 1
5Y Capital
Asia, Shanghai, China, Xuhui
Co-Investments: 1
China Merchants Venture
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
3P
North America, Missouri, United States, Saint Louis
Co-Investments: 1
Shanghai Lingang
Asia, Shanghai, China, Shanghai
Co-Investments: 1

What are some of recent deals done by SPDB International Holdings?

Kyligence

San Jose, California, United States

Kyligence is a data intelligence company that focuses on big data analytic technology innovation.

AnalyticsEnterprise SoftwareInformation TechnologySoftware
Series DApr 20, 2021
Amount Raised: $70,000,000
DEEPEXI

Beijing, Beijing, China

DEEPEXI provides the ability to implement productization and instrumentation, and accelerate the realization of digital transformation value

ArchitectureInternet
Series ADec 5, 2020
Amount Raised: $40,000,000
CANbridge Pharmaceuticals

Beijing, Beijing, China

CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare .

BiotechnologyHealth CarePharmaceutical
Series EDec 1, 2020
Amount Raised: $43,000,000